Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways (Q46966395)
Jump to navigation
Jump to search
scientific article published in February 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways |
scientific article published in February 2006 |
Statements
1 reference
Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways (English)
1 reference
ShouWei Han
1 reference
Jesse Roman
1 reference
1 February 2006
1 reference
1 reference
5
1 reference
430-437
1 reference
2
1 reference
Identifiers
1 reference
1 reference